Development of a Rabbit Human Glioblastoma Model for Testing of Endovascular Selective Intra-Arterial Infusion (ESIA) of Novel Stem Cell-Based Therapeutics
CONCLUSIONS: The intracranial immunosuppressed rabbit human GBM model allows testing of ESIA infusion of novel therapeutics (e.g., MSC-D24) in a clinically relevant fashion.PMID:37603323 | DOI:10.1093/neuonc/noad152
Source: Ann Oncol - Category: Cancer & Oncology Authors: Peter Kan Visish M Srinivasan Joy Gumin Roberto Garcia Stephen R Chen Jeremiah N Johnson Dalis E Collins Melissa M Chen Daniel Ledbetter Jason Huse Zean Aaron Evan Luna Ariadna Robledo Viren Vasandani Abhijit Rao Sanjay K Singh Elizabeth J Shpall Juan Fue Source Type: research
More News: Adenoviruses | Brain | Brain Cancers | Cancer & Oncology | Dexamethasone | MRI Scan | Neurology | Prograf | Stem Cell Therapy | Stem Cells | Tacrolimus